Table 1 Comparison of clinical and ultrasound data of benign and malignant patients with NML between training group and validation group.
Variables | Train group | Validation group | ||||||
---|---|---|---|---|---|---|---|---|
Benign NML (n = 269) | Malignant NML (n = 327) | t/ W/ χ2 | P | Benign NML (n = 129) | Malignant NML (n = 126) | t/ W/ χ2 | P | |
Age, Median (Q1, Q3) | 40 (34, 49) | 48 (42.5, 54) | 26840b | < 0.001 | 41 (34, 49) | 47 (39, 53) | 5874.5b | < 0.001 |
High, Median (Q1, Q3) | 160 (158, 165) | 160 (158, 165) | 45174b | 0.567 | 160 (158, 165) | 160 (158, 164) | 8635.5b | 0.386 |
Weigh, Median (Q1,Q3) | 62 (57, 70) | 60 (56, 67.67) | 49,475.5b | 0.009 | 63 (57, 70) | 61.01 (56, 68) | 9440.5b | 0.026 |
BMI, Median (Q1, Q3) | 1.66 (1.59, 1.74) | 1.64 (1.57, 1.72) | 49,133.5b | 0.014 | 1.682 ± 0.126 | 1.644 ± 0.124 | 2.419b | 0.016 |
Menarche age, Median (Q1, Q3) | 12 (12, 13) | 12 (12, 13) | 41930b | 0.248 | 12 (12, 13) | 12 (12, 12.75) | 8448.5b | 0.492 |
Menopause, n (%) | 26.542c | < 0.001 | 9.547c | 0.002 | ||||
No | 234 (86.989) | 225 (68.807) | 114 (88.372) | 91 (72.222) | ||||
Yes | 35 (13.011) | 102 (31.193) | 15 (11.628) | 35 (27.778) | ||||
Position, n (%) | 12.06c | 0.007 | 10.077c | 0.018 | ||||
Outer upper quadrant | 142 (52.788) | 210 (64.220) | 70 (54.264) | 84 (66.667) | ||||
Inner upper quadrant | 63 (23.420) | 61 (18.654) | 25 (19.380) | 28 (22.222) | ||||
Outer lower quadrant | 41 (15.242) | 45 (13.761) | 21 (16.279) | 10 (7.937) | ||||
Inner lower quadrant | 23 (8.550) | 11 (3.364) | 13 (10.078) | 4 (3.175) | ||||
Long diameter, Median (Q1, Q3) | 2 (1.1, 4.36) | 2.54 (1.7, 3.8) | 38,264.5b | 0.006 | 2.2 (1.4, 3.84) | 2.8 (1.83, 3.8) | 6991.5b | 0.054 |
Wide diameter, Median (Q1, Q3) | 0.9 (0.59, 1.6) | 1.1 (0.8, 1.6) | 36525b | < 0.001 | 1 (0.6, 1.7) | 1.2 (0.9, 1.6) | 6654.5b | 0.012 |
Focus orientation, n (%) | 0.020c | 0.887 | Fisher | 1 | ||||
Parallel | 261 (97.026) | 319 (97.554) | 126 (97.674) | 123 (97.619) | ||||
No parallel | 8 (2.974) | 8 (2.446) | 3 (2.326) | 3 (2.381) | ||||
Rear echo, n (%) | Fisher | < 0.001 | Fisher | < 0.001 | ||||
No change | 237 (88.104) | 256 (78.287) | 120 (93.023) | 98 (77.778) | ||||
Attenuation | 27 (10.037) | 71 (21.713) | 7 (5.426) | 28 (22.222) | ||||
Enhancement | 5 (1.859) | 0 (0) | 2 (1.550) | 0 (0) | ||||
Calcification , n (%) | 90.702c | < 0.001 | 45.974c | < 0.001 | ||||
No calcification | 211 (78.439) | 150 (45.872) | 86 (66.667) | 48 (38.095) | ||||
Coarse calcification | 28 (10.409) | 22 (6.728) | 24 (18.604) | 9 (7.143) | ||||
Fine calcification | 30 (11.152) | 155 (47.401) | 19 (14.729) | 69 (54.762) | ||||
Surrounding structure, n (%) | 21.947c | < 0.001 | 20.787c | < 0.001 | ||||
No twist | 147 (54.647) | 115 (35.168) | 71 (55.039) | 33 (26.190) | ||||
Twist | 122 (45.353) | 212 (64.832) | 58 (44.961) | 93 (73.810) | ||||
Blood flow characteristics, n (%) | 48.509c | < 0.001 | 21.372c | < 0.001 | ||||
Grade 0 | 119 (44.238) | 75 (22.936) | 56 (43.411) | 28 (22.222) | ||||
Grade I | 76 (28.253) | 73 (22.324) | 33 (25.581) | 24 (19.048) | ||||
Grade II | 40 (14.870) | 93 (28.440) | 24 (18.605) | 39 (30.952) | ||||
Grade III | 34 (12.639) | 86 (26.300) | 16 (12.403) | 35 (27.778) | ||||
Peripheral blood flow, n (%) | 2.636c | 0.104 | Fisher | 0.066 | ||||
None | 257 (95.539) | 321 (98.165) | 122 (94.574) | 125 (99.206) | ||||
Yes | 12 (4.461) | 6 (1.835) | 7 (5.426) | 1 (0.794) |